Performance evaluation of the Abbott RealTime HCV genotype II for hepatitis C virus genotyping

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 4, 2010, Pages 469-474

  Sohn, Yong Hak ^a   Ko, Sun Young ^b   Kim, Myeong Hee ^c   Oh, Heung Bum ^b  

^a Eulji University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

Genotype; Genotyping; HCV; Method evaluation; Real time PCR

Indexed keywords

VIRUS RNA;

ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CROSS REACTION; DIAGNOSTIC ACCURACY; GENOTYPE; HEPATITIS C VIRUS; LABORATORY AUTOMATION; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURNAROUND TIME; VIRUS DETECTION; VIRUS GENOME; VIRUS STRAIN;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 77949870919     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.093     Document Type: Article

References (28)

1. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-2100
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
3. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002;19:1-46.
4. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39: 1147-1171
5. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-1374
6. Hnatyszyn H. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005;10:1-11.
7. Arens M. Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV. J Clin Virol 2001;22:11-29.
8. Ansaldi F, Torre F, Bruzzone B, Picciotto A, Crovari P, Icardi G. Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping. J Med Virol 2001;63:17-21.
9. Verbeeck J, Stanley M, Shieh J, Celis L, Huyck E, Wollants E, et al. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol 2008;46:1901-1906.
10. Kim Y, Kim S, Chung H, Jee M, Kim B, Kim K, et al. Population genotyping of hepatitis C virus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of short DNA fragments. Clin Chem 2005;51:1123-1131
11. Chung HJ, Yang JH, Hwang SH, Hong SP, Oh HB. The comparison of restriction fragment mass polymorphism with sequencing method for the hepatitis C virus genotyping. Korean J Lab Med 2005;25:352-360
12. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42:962-973
13. Cook L, Sullivan K, Krantz E, Bagabag A, Jerome K. Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes. J Clin Microbiol 2006;44:4149-4156
14. Martro E, Gonzalez V, Buckton A, Saludes V, Fernandez G, Matas L, et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 59 noncoding and nonstructural 5b genomic regions. J Clin Microbiol 2008;46:192-197
15. Mizokami M, Gojobori T, Lau JY. Molecular evolutionary virology: its application to hepatitis C virus. Gastroenterology 1994;107:1181-1182
16. Fried M, Shiffman M, Reddy K, Smith C, Marinos G, Goncales FJ, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982
17. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996;23:695-699
18. Poynard T, McHutchison J, Goodman Z, Ling M, Albrecht J. Is an 'a la carte' combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group. Hepatology 2000;31:211-218
19. Zein N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000;13:223-235
20. Suh DJ, Jeong SH. Current status of hepatitis C virus infection in Korea. Intervirology 2006;49:70-75
21. Lindh M, Hannoun C. Genotyping of hepatitis C virus by Taqman real-time PCR. J Clin Virol 2005;34:108-114
22. Rolfe K, Alexander G, Wreghitt T, Parmar S, Jalal H, Curran M. A real-time Taqman method for hepatitis C virus genotyping. J Clin Virol 2005;34:115-121
23. Schroter M, Zollner B, Schafer P, Landt O, Lass U, Laufs R, et al. Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes. J Clin Microbiol 2002;40:2046-2050
24. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996;125:634-639
25. Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, et al. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand J Infect Dis 1997;29:17-22.
26. Chen Z, Weck K. Hepatitis C virus genotyping: interrogation of the 59 untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol 2002;40:3127-3134
27. Laperche S, Lunel F, Izopet J, Alain S, Deny P, Duverlie G, et al. Comparison of hepatitis C virus NS5b and 59 noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 2005;43:733-739
28. Stuyver L, Wyseur A, van Arnhem W, Lunel F, Laurent-Puig P, Pawlotsky JM, et al. Hepatitis C virus genotyping by means of 59-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 1995;38:137-157